STAT3 and malignant colon neoplasm: Consistently, in both models of inflammatory bowel disease and colitis-associated colon cancer, mice exhibited reduced NFκB activation and STAT3 activation, which has been linked to increased epithelial proliferation [158], and decreased expression of pro-inflammatory cytokines and chemokines [159].